Our platform merges cutting-edge telehealth innovations with clinically proven, personalized weight loss solutions
Gastroenterology 161 , 66-80 (2021).
CagriSema (semaglutide + cagrilintide), filed by Novo Nordisk in December 2025, achieved 22.7% weight loss in trials and could receive FDA approval in 2026
- Cng ngh Liposome : ci thin kh nng hp th v vn chuyn cc cht dng vo tn su trong ln da, bo v cc hot cht khng b bin i do tc ng ca mi trng, c th pht hin c cc t bo h tn gii phng hot cht mt cch hiu qu v an ton
Copper is a co-factor for DAO activity
However, if you do choose to combine these two treatments, its important that you are at or near your ideal body weight, as laser liposuction cannot be used for significant fat reduction